[go: up one dir, main page]

AU5347496A - Ethynylthiazole derivative - Google Patents

Ethynylthiazole derivative

Info

Publication number
AU5347496A
AU5347496A AU53474/96A AU5347496A AU5347496A AU 5347496 A AU5347496 A AU 5347496A AU 53474/96 A AU53474/96 A AU 53474/96A AU 5347496 A AU5347496 A AU 5347496A AU 5347496 A AU5347496 A AU 5347496A
Authority
AU
Australia
Prior art keywords
ethynylthiazole
derivative
ethynylthiazole derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53474/96A
Inventor
Makoto HARUTA
Nobuo Machinaga
Manabu Matsumura
Atsushi Nakayama
Tomomi OGASAWARA
Toshiyuki Takeda
Hitoshi Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU5347496A publication Critical patent/AU5347496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU53474/96A 1995-04-21 1996-04-19 Ethynylthiazole derivative Abandoned AU5347496A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7-97002 1995-04-21
JP9700295 1995-04-21
PCT/JP1996/001079 WO1996033181A1 (en) 1995-04-21 1996-04-19 Ethynylthiazole derivative

Publications (1)

Publication Number Publication Date
AU5347496A true AU5347496A (en) 1996-11-07

Family

ID=14180020

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53474/96A Abandoned AU5347496A (en) 1995-04-21 1996-04-19 Ethynylthiazole derivative

Country Status (3)

Country Link
JP (1) JPH11506425A (en)
AU (1) AU5347496A (en)
WO (1) WO1996033181A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956049B1 (en) * 1999-08-31 2005-10-18 Merck & Co., Inc. Methods of modulating processes mediated by excitatory amino acid receptors
IT1320162B1 (en) 2000-02-09 2003-11-18 Rotta Research Lab DERIVATIVES OF THYROSIN WITH ANTI LEUKOTRIENIC ACTIVITY, PROCEDURES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE.
JP4527231B2 (en) * 2000-03-17 2010-08-18 持田製薬株式会社 Inhibitor of abnormal smooth muscle contraction
US7056917B2 (en) 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
JP4164028B2 (en) * 2001-10-12 2008-10-08 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Alkyne matrix metalloproteinase inhibitors
WO2007009959A1 (en) * 2005-07-15 2007-01-25 Laboratoires Serono S.A. Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders
JP2009108036A (en) * 2007-09-28 2009-05-21 Fujifilm Corp New acetylenic compound, method for producing the same, polymer containing the compound as constitutional unit, composition containing the compound and/or the polymer and cured material produced by curing the composition
JP2010053435A (en) * 2008-08-29 2010-03-11 Showa Denko Kk Sensitizing solution for electroless plating, and electroless plating method
TW201124391A (en) 2009-10-20 2011-07-16 Lundbeck & Co As H 2-substituted-ethynylthiazole derivatives and uses of same
CN106146391A (en) * 2015-04-15 2016-11-23 中国科学院上海药物研究所 Substituted benzamide compound of 5-fragrance alkynyl and preparation method thereof, pharmaceutical composition and purposes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2341687A (en) * 1940-12-04 1944-02-15 Ici Ltd Manufacture of thiazoles
JPS62142168A (en) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd Thiazole derivative and leukotriene antagonistic agent containing said derivative as active ingredient
EP0355353B1 (en) * 1988-07-15 1994-03-16 F. Hoffmann-La Roche Ag Cycloalkylthiazole derivatives
US5273986A (en) * 1992-07-02 1993-12-28 Hoffmann-La Roche Inc. Cycloalkylthiazoles
US5288751A (en) * 1992-11-06 1994-02-22 Abbott Laboratories [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis

Also Published As

Publication number Publication date
JPH11506425A (en) 1999-06-08
WO1996033181A1 (en) 1996-10-24

Similar Documents

Publication Publication Date Title
AU4665596A (en) Pyrazolylbenzoyl derivatives
AU4780896A (en) Core-board
AU6304196A (en) Substituted cyanophenyluracils
AU7626596A (en) Oxymethoxy-3-aryl-pyrone derivatives
AU4086296A (en) Indolepiperidine derivatives
AU1195897A (en) Heteroarylcarboxamide derivatives
AU1030997A (en) Taphane
AU7053296A (en) Purin-6-one derivatives
AU4875296A (en) Isoxazolyl-benzoyl derivatives
AU5763596A (en) 2-ureido-benzamide derivatives
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU6191796A (en) Sulfonyl- or sulfinylbenzoylguanidine derivatives
AU7084796A (en) Diarylalkenylamine derivatives
AU5347496A (en) Ethynylthiazole derivative
AU4547796A (en) Hexahydropyrazinoquinoline derivatives
AU5052296A (en) 4-indolylpiperazinyl derivatives
AU4382896A (en) Acetylimidazobenzodiazepines
AU6929696A (en) Pyrazol-4-ylbenzoyl derivatives
AU4211296A (en) 4-aminobenzoylguanidine derivatives
AU6304396A (en) Substituted carbonylaminophenyluracils
AU4547396A (en) Thioquinoline derivatives
AU6214896A (en) Alkenyl-benzoylguanidine derivatives
AU5013796A (en) Wireclamp
AU4220096A (en) 4-mercaptobenzoylguanidine derivatives
AU5107096A (en) Haemodialyser